Reuters logo
8 months ago
BRIEF-Biogen says separation of Bioverativ to be completed on Feb 1
December 22, 2016 / 9:59 PM / 8 months ago

BRIEF-Biogen says separation of Bioverativ to be completed on Feb 1

Dec 22 (Reuters) - Biogen Inc :

* Says separation of Bioverativ as independent company expected to be completed on February 1, 2017

* Biogen Inc - Nasdaq has advised that Nioverativ common stock will begin trading on a "when-issued" basis under symbol "BIVV WI" on Jan 12, 2017

* Biogen Inc - Nasdaq has approved listing of Bioverativ common stock on Nasdaq Global Select Market under symbol "BIVV"

* Biogen announces effectiveness of Bioverativ Form 10 registration statement

* Says Bioverativ common stock approved for listing on Nasdaq Global Select Market Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below